Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Busulfan, and Melphalan before Stem Cell Transplant in Relapsed/Refractory Hodgkin's Disease
NCT01200329Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2011
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Hodgkin lymphoma (HL), sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2011; status: completed.
02
Drugs
gemcitabine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01200329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200329.